KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

HCA Healthcare (HCA) EPS (Weighted Average and Diluted) (2016 - 2026)

HCA Healthcare (HCA) has disclosed EPS (Weighted Average and Diluted) for 17 consecutive years, with $7.15 as the latest value for Q1 2026.

  • For Q1 2026, EPS (Weighted Average and Diluted) rose 10.85% year-over-year to $7.15; the TTM value through Mar 2026 reached $29.04, up 29.12%, while the annual FY2025 figure was $28.33, 28.77% up from the prior year.
  • EPS (Weighted Average and Diluted) hit $7.15 in Q1 2026 for HCA Healthcare, down from $8.1 in the prior quarter.
  • Across five years, EPS (Weighted Average and Diluted) topped out at $8.1 in Q4 2025 and bottomed at $3.9 in Q2 2022.
  • Average EPS (Weighted Average and Diluted) over 5 years is $5.62, with a median of $5.63 recorded in 2024.
  • Year-over-year, EPS (Weighted Average and Diluted) crashed 44.14% in 2022 and then soared 43.87% in 2025.
  • HCA Healthcare's EPS (Weighted Average and Diluted) stood at $7.18 in 2022, then dropped by 17.83% to $5.9 in 2023, then dropped by 4.58% to $5.63 in 2024, then skyrocketed by 43.87% to $8.1 in 2025, then dropped by 11.73% to $7.15 in 2026.
  • According to Business Quant data, EPS (Weighted Average and Diluted) over the past three periods came in at $7.15, $8.1, and $6.96 for Q1 2026, Q4 2025, and Q3 2025 respectively.